false2025Q23/290000772406P1Y452498xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purecrus:derivativeContractcrus:segmentcrus:product_line00007724062024-03-312024-09-2800007724062024-10-3100007724062024-09-2800007724062024-03-3000007724062024-06-302024-09-2800007724062023-06-252023-09-2300007724062023-03-262023-09-2300007724062023-03-2500007724062023-09-230000772406us-gaap:CommonStockMember2023-06-240000772406us-gaap:AdditionalPaidInCapitalMember2023-06-240000772406us-gaap:RetainedEarningsMember2023-06-240000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-2400007724062023-06-240000772406us-gaap:RetainedEarningsMember2023-06-252023-09-230000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-252023-09-230000772406us-gaap:CommonStockMember2023-06-252023-09-230000772406us-gaap:AdditionalPaidInCapitalMember2023-06-252023-09-230000772406us-gaap:CommonStockMember2023-09-230000772406us-gaap:AdditionalPaidInCapitalMember2023-09-230000772406us-gaap:RetainedEarningsMember2023-09-230000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-230000772406us-gaap:CommonStockMember2024-06-290000772406us-gaap:AdditionalPaidInCapitalMember2024-06-290000772406us-gaap:RetainedEarningsMember2024-06-290000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-2900007724062024-06-290000772406us-gaap:RetainedEarningsMember2024-06-302024-09-280000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-302024-09-280000772406us-gaap:CommonStockMember2024-06-302024-09-280000772406us-gaap:AdditionalPaidInCapitalMember2024-06-302024-09-280000772406us-gaap:CommonStockMember2024-09-280000772406us-gaap:AdditionalPaidInCapitalMember2024-09-280000772406us-gaap:RetainedEarningsMember2024-09-280000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-280000772406us-gaap:CommonStockMember2023-03-250000772406us-gaap:AdditionalPaidInCapitalMember2023-03-250000772406us-gaap:RetainedEarningsMember2023-03-250000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-250000772406us-gaap:RetainedEarningsMember2023-03-262023-09-230000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-262023-09-230000772406us-gaap:CommonStockMember2023-03-262023-09-230000772406us-gaap:AdditionalPaidInCapitalMember2023-03-262023-09-230000772406us-gaap:CommonStockMember2024-03-300000772406us-gaap:AdditionalPaidInCapitalMember2024-03-300000772406us-gaap:RetainedEarningsMember2024-03-300000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-300000772406us-gaap:RetainedEarningsMember2024-03-312024-09-280000772406us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-312024-09-280000772406us-gaap:CommonStockMember2024-03-312024-09-280000772406us-gaap:AdditionalPaidInCapitalMember2024-03-312024-09-280000772406us-gaap:DomesticCorporateDebtSecuritiesMember2024-09-280000772406us-gaap:USTreasurySecuritiesMember2024-09-280000772406us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-280000772406us-gaap:CommercialPaperMember2024-09-280000772406srt:MinimumMember2024-03-312024-09-280000772406srt:MaximumMember2024-03-312024-09-280000772406us-gaap:DomesticCorporateDebtSecuritiesMember2024-03-300000772406us-gaap:USTreasurySecuritiesMember2024-03-300000772406us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-03-300000772406us-gaap:CommercialPaperMember2024-03-300000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-03-202023-03-200000772406us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2024-09-280000772406us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2024-09-280000772406us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2024-09-280000772406us-gaap:MoneyMarketFundsMember2024-09-280000772406us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-09-280000772406us-gaap:CorporateDebtSecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasurySecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasurySecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-09-280000772406us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2024-09-280000772406us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2024-09-280000772406us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialPaperMember2024-09-280000772406us-gaap:FairValueInputsLevel1Member2024-09-280000772406us-gaap:FairValueInputsLevel2Member2024-09-280000772406us-gaap:FairValueInputsLevel3Member2024-09-280000772406us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2024-03-300000772406us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2024-03-300000772406us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2024-03-300000772406us-gaap:MoneyMarketFundsMember2024-03-300000772406us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2024-03-300000772406us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Member2024-03-300000772406us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Member2024-03-300000772406us-gaap:CertificatesOfDepositMember2024-03-300000772406us-gaap:FairValueInputsLevel1Member2024-03-300000772406us-gaap:FairValueInputsLevel2Member2024-03-300000772406us-gaap:FairValueInputsLevel3Member2024-03-300000772406us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-03-300000772406us-gaap:CorporateDebtSecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasurySecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasurySecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-03-300000772406us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2024-03-300000772406us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2024-03-300000772406us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialPaperMember2024-03-300000772406us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2024-06-302024-09-280000772406us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2023-06-252023-09-230000772406us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2024-03-312024-09-280000772406us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2023-03-262023-09-230000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember2021-07-080000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMembercrus:VariableRateComponentTwoMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2021-07-082021-07-080000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMembercrus:VariableRateComponentTwoMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2021-07-082021-07-080000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2023-03-202023-03-200000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2023-03-202023-03-200000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMembersrt:MinimumMember2021-07-082021-07-080000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMembersrt:MaximumMember2021-07-082021-07-080000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember2021-07-082021-07-080000772406crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember2024-09-280000772406crus:AudioProductsSegmentMember2024-06-302024-09-280000772406crus:AudioProductsSegmentMember2023-06-252023-09-230000772406crus:AudioProductsSegmentMember2024-03-312024-09-280000772406crus:AudioProductsSegmentMember2023-03-262023-09-230000772406crus:HighPerformanceMixedSignalProductsMember2024-06-302024-09-280000772406crus:HighPerformanceMixedSignalProductsMember2023-06-252023-09-230000772406crus:HighPerformanceMixedSignalProductsMember2024-03-312024-09-280000772406crus:HighPerformanceMixedSignalProductsMember2023-03-262023-09-230000772406country:CN2024-06-302024-09-280000772406country:CN2023-06-252023-09-230000772406country:CN2024-03-312024-09-280000772406country:CN2023-03-262023-09-230000772406country:US2024-06-302024-09-280000772406country:US2023-06-252023-09-230000772406country:US2024-03-312024-09-280000772406country:US2023-03-262023-09-230000772406crus:OtherCountriesMember2024-06-302024-09-280000772406crus:OtherCountriesMember2023-06-252023-09-230000772406crus:OtherCountriesMember2024-03-312024-09-280000772406crus:OtherCountriesMember2023-03-262023-09-230000772406us-gaap:EmployeeSeveranceMember2023-03-262024-03-3000007724062021-07-282021-07-280000772406crus:July2022RepurchaseProgramMember2022-07-310000772406crus:July2022RepurchaseProgramMember2022-07-312024-09-280000772406crus:July2022RepurchaseProgramMember2024-09-280000772406crus:July2022RepurchaseProgramMember2024-06-302024-09-280000772406crus:July2022RepurchaseProgramMember2024-03-312024-09-280000772406crus:ScottThomasMember2024-06-302024-09-280000772406crus:ScottThomasMember2024-09-280000772406crus:JeffBaumgartnerMember2024-06-302024-09-280000772406crus:JeffBaumgartnerMember2024-09-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 28, 2024
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from ____ to ____
Commission File Number 0-17795
CIRRUS LOGIC, INC.
(Exact name of registrant as specified in its charter)
Delaware 77-0024818
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
800 W. 6th StreetAustin,Texas78701
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code:(512)851-4000


 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stock, $0.001 par valueCRUSThe NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.  Yes   No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes       No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-accelerated Filer  
Smaller Reporting Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.     
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 
Yes ☐    No
The number of shares of the registrant's common stock, $0.001 par value, outstanding as of October 31, 2024 was 53,139,913.




CIRRUS LOGIC, INC.
FORM 10-Q QUARTERLY REPORT
QUARTERLY PERIOD ENDED SEPTEMBER 28, 2024
TABLE OF CONTENTS
PART I - FINANCIAL INFORMATION
 
Item 1.Financial Statements 
 
Consolidated Condensed Balance Sheets - September 28, 2024 (unaudited) and March 30, 2024
  
Consolidated Condensed Statements of Income (unaudited) - Three and Six Months Ended September 28, 2024 and September 23, 2023
  
Consolidated Condensed Statements of Comprehensive Income (unaudited) - Three and Six Months Ended September 28, 2024 and September 23, 2023
  
Consolidated Condensed Statements of Cash Flows (unaudited) - Six Months Ended September 28, 2024 and September 23, 2023
Consolidated Condensed Statements of Stockholders' Equity (unaudited) - Three and Six Months Ended September 28, 2024 and September 23, 20237
Notes to Consolidated Condensed Financial Statements (unaudited)
  
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
  
Item 3.Quantitative and Qualitative Disclosures about Market Risk
  
Item 4.Controls and Procedures
  
PART II - OTHER INFORMATION
  
Item 1.Legal Proceedings
  
Item 1A.Risk Factors
  
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
  
Item 3.Defaults Upon Senior Securities
  
Item 4.Mine Safety Disclosures
  
Item 5.Other Information
  
Item 6.Exhibits
  
Signatures

2


Part I. FINANCIAL INFORMATION
ITEM 1.  FINANCIAL STATEMENTS
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)
September 28,March 30,
20242024
(unaudited) 
Assets  
Current assets:  
Cash and cash equivalents$445,759 $502,764 
Marketable securities32,499 23,778 
Accounts receivable, net324,098 162,478 
Inventories271,765 227,248 
Prepaid assets49,594 48,047 
Prepaid wafers71,740 86,679 
Other current assets29,450 55,198 
Total current assets1,224,905 1,106,192 
  
Long-term marketable securities228,302 173,374 
Right-of-use lease assets133,316 138,288 
Property and equipment, net168,265 170,175 
Intangibles, net25,700 29,578 
Goodwill435,936 435,936 
Deferred tax assets48,619 48,649 
Long-term prepaid wafers37,804 60,750 
Other assets53,292 68,634 
Total assets$2,356,139 $2,231,576 
  
Liabilities and Stockholders' Equity  
Current liabilities:  
Accounts payable$91,899 $55,545 
Accrued salaries and benefits51,861 47,612 
Software license agreements26,643 31,866 
Current lease liabilities22,800 20,640 
Other accrued liabilities36,073 30,730 
Total current liabilities229,276 186,393 
  
Long-term liabilities:  
Non-current lease liabilities129,806 134,576 
Non-current income taxes42,683 52,013 
Software license agreements26,223 41,073 
Other long-term liabilities24 507 
Total long-term liabilities198,736 228,169 
  
Stockholders' equity:  
Capital stock1,819,589 1,760,701 
Accumulated earnings107,233 58,916 
Accumulated other comprehensive income (loss)1,305 (2,603)
Total stockholders' equity1,928,127 1,817,014 
Total liabilities and stockholders' equity$2,356,139 $2,231,576 

The accompanying notes are an integral part of these consolidated condensed financial statements.
3



CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(in thousands, except per share amounts; unaudited)
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Net sales$541,857 $481,063 $915,883 $798,079 
Cost of sales259,267 234,467 444,368 392,096 
Gross profit282,590 246,596 471,515 405,983 
Operating expenses  
Research and development112,925 104,205 218,288 210,420 
Selling, general and administrative37,813 34,323 74,583 69,702 
Restructuring costs 2,319  2,319 
Total operating expenses150,738 140,847 292,871 282,441 
Income from operations131,852 105,749 178,644 123,542 
Interest income8,378 3,972 16,798 8,791 
Interest expense(244)(243)(462)(462)
Other income (expense)19 (70)1,628 307 
Income before income taxes140,005 109,408 196,608 132,178 
Provision for income taxes37,865 34,001 52,373 41,171 
Net income$102,140 $75,407 $144,235 $91,007 
  
Basic earnings per share$1.92 $1.38 $2.70 $1.66 
Diluted earnings per share$1.83 $1.34 $2.59 $1.61 
Basic weighted average common shares outstanding53,275 54,503 53,354 54,683 
Diluted weighted average common shares outstanding55,800 56,278 55,753 56,453 

The accompanying notes are an integral part of these consolidated condensed financial statements.
4


CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands; unaudited)
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Net income$102,140 $75,407 $144,235 $91,007 
Other comprehensive loss, before tax  
Foreign currency translation gain (loss)717 (342)359 (792)
Unrealized gain on marketable securities4,851 259 4,493 239 
Provision for income taxes(1,019)(54)(944)(50)
Comprehensive income $106,689 $75,270 $148,143 $90,404 

The accompanying notes are an integral part of these consolidated condensed financial statements.
5



CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(in thousands; unaudited)
Six Months Ended
September 28,September 23,
20242023
Cash flows from operating activities:  
Net income$144,235 $91,007 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:  
Depreciation and amortization24,977 23,551 
Stock-based compensation expense43,832 44,046 
Deferred income taxes(913)(8,601)
Loss on retirement or write-off of long-lived assets12 64 
Other non-cash adjustments1,191 1,608 
Restructuring costs 2,319 
Net change in operating assets and liabilities:  
Accounts receivable(161,620)(121,606)
Inventories(44,517)(95,480)
Prepaid wafers37,885 21,058 
Other assets(5,800)(6,291)
Accounts payable and other accrued liabilities39,305 (78)
Income taxes payable16,805 7,220 
Acquisition-related liabilities (21,361)
Net cash provided by (used in) operating activities95,392 (62,544)
  
Cash flows from investing activities:  
Maturities and sales of available-for-sale marketable securities13,481 18,242 
Purchases of available-for-sale marketable securities(72,637)(21,191)
Purchases of property, equipment and software(12,660)(20,780)
Investments in technology(225)(57)
Net cash used in investing activities(72,041)(23,786)
  
Cash flows from financing activities:  
Net proceeds from the issuance of common stock15,055 560 
Repurchase of stock to satisfy employee tax withholding obligations(4,426)(3,129)
Repurchase and retirement of common stock(90,985)(79,080)
Net cash used in financing activities(80,356)(81,649)
  
Net decrease in cash and cash equivalents(57,005)(167,979)
  
Cash and cash equivalents at beginning of period502,764 445,784 
Cash and cash equivalents at end of period$445,759 $277,805 

The accompanying notes are an integral part of these consolidated condensed financial statements.
6


CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands; unaudited)
Common StockAdditional Paid-In CapitalAccumulated Earnings (Deficit)Accumulated Other Comprehensive LossTotal
Three Months EndedSharesAmount
Balance, June 24, 202354,670 $55 $1,693,365 $(33,621)$(3,005)$1,656,794 
Net income— — — 75,407 — 75,407 
Change in unrealized gain (loss) on marketable securities, net of tax— — — — 205 205 
Change in foreign currency translation adjustments— — — — (342)(342)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes78 — — (2,080)— (2,080)
Repurchase and retirement of common stock(511)(1)— (40,919)— (40,920)
Stock-based compensation— — 19,291 — — 19,291 
Balance, September 23, 202354,237 $54 $1,712,656 $(1,213)$(3,142)$1,708,355 
Balance, June 29, 202453,335 $53 $1,792,230 $58,591 $(3,244)$1,847,630 
Net income— — — 102,140 — 102,140 
Change in unrealized gain (loss) on marketable securities, net of tax— — — — 3,832 3,832 
Change in foreign currency translation adjustments— — — — 717 717 
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes154 — 4,859 (3,207)— 1,652 
Repurchase and retirement of common stock(357)— — (50,291)— (50,291)
Stock-based compensation— — 22,447 — — 22,447 
Balance, September 28, 202453,132 $53 $1,819,536 $107,233 $1,305 $1,928,127 
Six Months Ended
Balance, March 25, 202355,098 $55 $1,670,086 $(9,320)$(2,539)$1,658,282 
Net income— — — 91,007 — 91,007 
Change in unrealized gain (loss) on marketable securities, net of tax— — — — 189 189 
Change in foreign currency translation adjustments— — — — (792)(792)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes116 — 564 (3,126)— (2,562)
Repurchase and retirement of common stock(977)(1)— (79,774)— (79,775)
Stock-based compensation— — 42,006 — — 42,006 
Balance, September 23, 202354,237 $54 $1,712,656 $(1,213)$(3,142)$1,708,355 
Balance, March 30, 202453,491 $53 $1,760,648 $58,916 $(2,603)$1,817,014 
Net income— — — 144,235 — 144,235 
Change in unrealized gain (loss) on marketable securities, net of tax— — — — 3,549 3,549 
Change in foreign currency translation adjustments— — — — 359 359 
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes359 — 15,056 (4,426)— 10,630 
Repurchase and retirement of common stock(718)— — (91,492)— (91,492)
Stock-based compensation— — 43,832 — — 43,832 
Balance, September 28, 202453,132 $53 $1,819,536 $107,233 $1,305 $1,928,127 

The accompanying notes are an integral part of these consolidated condensed financial statements.

7


CIRRUS LOGIC, INC.
NOTES TO THE CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(unaudited)
1. Basis of Presentation

The unaudited consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”).  The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations.  As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 30, 2024, included in our Annual Report on Form 10-K filed with the Commission on May 24, 2024.  In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented.  The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses.  Actual results could differ from those estimates and assumptions.  Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.

2. Recently Issued Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU requires (1) interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of a segment’s profit or loss, (2) interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, and (3) disclosure of the position and title of the CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. In the event the CODM uses more than one measure of a segment's profit or loss in assessing performance and allocation of resources, clarification of disclosure requirements is provided. Additionally, a company with a single reportable segment is required to provide all the disclosures prescribed under this ASU. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, to be applied retrospectively to all periods presented, with early adoption permitted. The Company is currently evaluating the impact of this new guidance on the financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted. The Company is currently evaluating the impact of this guidance on the financial statements and related disclosures.

3. Marketable Securities

The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the Consolidated Condensed Balance Sheet as "Marketable securities", within the short-term or long-term classification, as appropriate, based on the original maturity.

The following table is a summary of available-for-sale securities at September 28, 2024 (in thousands):
As of September 28, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$245,715 $3,513 $(40)$249,188 
U.S. Treasury securities10,212 135 (6)10,341 
Agency discount notes385  (2)383 
Commercial paper889   889 
Total securities$257,201 $3,648 $(48)$260,801 

The Company typically invests in highly-rated securities with original maturities generally ranging from one to three years. The Company's specifically identified gross unrealized losses, relating to securities with total amortized costs of approximately $10.8 million at September 28, 2024, were immaterial. Securities in a continuous unrealized loss position for
8


more than 12 months as of September 28, 2024 had an aggregate amortized cost of $8.7 million and an immaterial amount of aggregate unrealized loss. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of September 28, 2024, the Company does not consider any of its investments to be impaired.

The following table is a summary of available-for-sale securities at March 30, 2024 (in thousands):
As of March 30, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$186,194 $115 $(916)$185,393 
U.S. Treasury securities9,850  (81)9,769 
Agency discount notes1,135  (11)1,124 
Commercial paper866   866 
Total securities$198,045 $115 $(1,008)$197,152 

The Company's specifically identified gross unrealized losses of $1.0 million related to securities with total amortized costs of approximately $172.1 million at March 30, 2024. Securities in a continuous unrealized loss position for more than 12 months as of March 30, 2024 had an aggregate amortized cost of $25.0 million and an aggregate unrealized loss of $0.3 million. As of March 30, 2024, the Company did not consider any of its investments to be impaired.

The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):
September 28, 2024March 30, 2024
AmortizedEstimatedAmortizedEstimated
CostFair ValueCostFair Value
Within 1 year$32,450 $32,499 $24,071 $23,778 
After 1 year224,751 228,302 173,974 173,374 
Total$257,201 $260,801 $198,045 $197,152 

4. Fair Value of Financial Instruments

The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, U.S Treasury securities, securities of U.S. government-sponsored enterprises, and commercial paper and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term
9


marketable securities.  The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.

The Company's long-term revolving credit facility, described in Note 8 - Revolving Credit Facility, bears interest at a base rate plus applicable margin or forward-looking secured overnight financing rate ("Term SOFR") plus 10 basis points plus applicable margin. As of September 28, 2024, there are no amounts drawn under the facility and the fair value is zero.

As of September 28, 2024 and March 30, 2024, the Company has no Level 3 assets or liabilities.  There were no transfers between Level 1, Level 2, or Level 3 measurements for the three months ended September 28, 2024. 

The following summarizes the fair value of our financial instruments at September 28, 2024 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:    
Cash equivalents    
Money market funds$383,276 $ $ $383,276 
Available-for-sale securities    
Corporate debt securities$ $249,188 $ $249,188 
U.S. Treasury securities10,341   10,341 
Agency discount notes 383  383 
Commercial paper 889  889 
$10,341 $250,460 $ $260,801 

The following summarizes the fair value of our financial instruments at March 30, 2024 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:
Cash equivalents    
Money market funds$439,065 $ $ $439,065 
Certificates of deposit 400  400 
$439,065 $400 $ $439,465 
Available-for-sale securities    
Corporate debt securities$ $185,393 $ $185,393 
U.S. Treasury securities9,769   9,769 
Agency discount notes 1,124  1,124 
Commercial paper 866  866 
$9,769 $187,383 $ $197,152 

10



5. Derivative Financial Instruments

Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within "Other income (expense)" in the Consolidated Condensed Statements of Income. The Company does not apply hedge accounting to these foreign currency derivative instruments.

As of September 28, 2024, the Company held one foreign currency forward contract denominated in British Pound Sterling with a notional value of $17.4 million. The fair value of this contract was not material as of September 28, 2024.

The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023Location
Gain (loss) recognized in income:
Foreign currency forward contracts$684 $(195)$652 $(473)Other income (expense)
    

6. Accounts Receivable, net

The following are the components of accounts receivable, net (in thousands):
September 28,March 30,
20242024
Gross accounts receivable$324,098 $162,478 
Allowance for doubtful accounts  
Accounts receivable, net$324,098 $162,478 


7. Inventories

Inventories are comprised of the following (in thousands):
September 28,March 30,
20242024
Work in process$183,001 $130,842 
Finished goods88,764 96,406 
$271,765 $227,248 


8. Revolving Credit Facility

On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the "Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative
11


agent. The Amendment updates the benchmark interest rate provisions to replace the London interbank offered rate ("LIBOR") with the forward-looking overnight financing rate ("Term SOFR"), for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.

Borrowings under the Revolving Credit Facility may, at Cirrus Logic’s election, bear interest at either (a) a base rate plus the applicable margin ("Base Rate Loans") or (b) a Term SOFR rate plus a 10 basis point credit spread adjustment plus the applicable margin. The applicable margin ranges from 0% to 0.75% per annum for Base Rate Loans and 1.00% to 1.75% per annum for SOFR Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of four consecutive fiscal quarters (the “Consolidated Leverage Ratio”). A Commitment Fee accrues at a rate per annum ranging from 0.175% to 0.275% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders.

The Revolving Credit Facility contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $200 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 3.00 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 3.00 to 1.00 (the “Consolidated Interest Coverage Ratio”). The Second Amended Credit Agreement also contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. Further, the Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations.

As of September 28, 2024, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.  

9. Revenues

Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal ("HPMS").

Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Audio Products$316,588 $282,855 $535,558 $478,661 
HPMS Products225,269 198,208 380,325 319,418 
$541,857 $481,063 $915,883 $798,079 

The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
China$325,742 $279,066 $531,450 $469,928 
United States2,471 4,883 7,687 7,042 
Rest of World213,644 197,114 376,746 321,109 
$541,857 $481,063 $915,883 $798,079 

12



10. Restructuring Costs

In fiscal year 2023, the Company decided to abandon or sublease office space at various properties worldwide to align our real property lease arrangements with our anticipated operating needs. In addition, in fiscal year 2024, the Company announced a workforce reduction of approximately 5% of its global employees. The Company incurred associated severance and other related charges of $2.3 million in the second quarter of fiscal year 2024. As of September 28, 2024, remaining restructuring-related liabilities were immaterial and are expected to be substantially paid out in cash during fiscal year 2025.

11. Income Taxes

Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, and any applicable income tax credits.

The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Income before income taxes$140,005 $109,408 $196,608 $132,178 
Provision for income taxes$37,865 $34,001 $52,373 $41,171 
Effective tax rate27.0 %31.1 %26.6 %31.1 %

Our income tax expense was $37.9 million and $34.0 million for the second quarters of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 27.0 percent and 31.1 percent, respectively. Our income tax expense was $52.4 million and $41.2 million for the first six months of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 26.6 percent and 31.1 percent, respectively. 

Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires research and development ("R&D") expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, resulting in higher global intangible low-taxed income ("GILTI"), which is treated as a period cost. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI. Our effective tax rates for the periods presented were higher than the federal statutory rate primarily due to these two items, partially offset by the effect of income earned in certain foreign jurisdictions that is taxed below the federal statutory rate.

The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns.  At September 28, 2024, the Company had unrecognized tax benefits of $32.1 million, all of which would impact the effective tax rate if recognized.  The Company’s total unrecognized tax benefits are classified as “Non-current income taxes" in the Consolidated Condensed Balance Sheets. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes.  As of September 28, 2024, the balance of accrued interest and penalties, net of tax, was $10.6 million. 

On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved in the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits. The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2017 through 2019 and 2021 through 2024 remain open to examination by the major taxing jurisdictions in which the Company operates.  
13



The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service ("IRS").  The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies. The final Revenue Agent’s Report asserted additional tax of approximately $168.3 million, excluding interest, and imposed penalties of approximately $63.7 million. The Company does not agree with the IRS's positions and has not accrued an additional liability. In July 2024, the Company entered the administrative dispute process with the IRS Independent Office of Appeals ("IRS Appeals"). We intend to vigorously dispute the proposed adjustments and pursue judicial remedies if an acceptable outcome cannot be reached with IRS Appeals. The Company expects it could take a number of years to reach resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes adequate amounts have been reserved in accordance with ASC 740 for any adjustments to the provision for income taxes that may ultimately result. However, if the IRS prevails in these matters, the ultimate amount of assessed tax, interest, and penalties, if any, could be material and may have an adverse impact on our financial position, results of operations, and cash flows in future periods. The Company is not under an income tax audit in any other major taxing jurisdiction.

12. Net Income Per Share

Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  These potentially dilutive items consist primarily of outstanding stock options and restricted stock grants.

The following table details the calculation of basic and diluted earnings per share for the three and six months ended September 28, 2024 and September 23, 2023 (in thousands, except per share amounts):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Numerator:    
Net income$102,140 $75,407 $144,235 $91,007 
Denominator:    
Weighted average shares outstanding53,275 54,503 53,354 54,683 
Effect of dilutive securities2,525 1,775 2,399 1,770 
Weighted average diluted shares55,800 56,278 55,753 56,453 
Basic earnings per share$1.92 $1.38 $2.70 $1.66 
Diluted earnings per share$1.83 $1.34 $2.59 $1.61 

The weighted outstanding shares excluded from our diluted calculation for the three and six months ended September 28, 2024 were 8 thousand and 229 thousand, respectively, as the shares were anti-dilutive. The weighted outstanding shares excluded from our diluted calculation for the three and six months ended September 23, 2023 were 393 thousand and 364 thousand, respectively, as the shares were anti-dilutive.

13. Commitments and Contingencies

Capacity Reservation Agreement

On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GlobalFoundries to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”).

The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments. In exchange for GlobalFoundries’ capacity commitment, the Company paid a $60 million non-refundable capacity reservation fee, which is amortized over the Commitment Period. The balance of this reservation fee is $24 million as of September 28, 2024, and is
14


recorded in "Other current assets" and "Other assets" on the Consolidated Condensed Balance Sheets within the short-term or long-term classification, as appropriate. In addition, the Company pre-paid GlobalFoundries $195 million for future wafer purchases, which are credited back to the Company as a portion of the price of wafers purchased, which began in the Company's second fiscal quarter of 2024. The balance of the prepayment is $110 million at September 28, 2024, and is currently recorded in "Long-term prepaid wafers" and "Prepaid wafers" on the Consolidated Condensed Balance Sheets.

14. Legal Matters

From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities.  We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate.  We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.    

Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows.  However, we are engaged in various legal actions in the normal course of business.  There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.

15. Stockholders' Equity

Common Stock 

The Company issued a net 0.2 million and 0.4 million of shares of common stock during each of the three and six months ended September 28, 2024, and issued a net 0.1 million of shares of common stock for both the three and six months ended September 23, 2023 pursuant to the Company's equity incentive plans.

Share Repurchase Program 

The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity. As of September 28, 2024, the Company has accrued approximately $1.8 million related to this excise tax. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.

In July 2022, the Board of Directors authorized the repurchase of up to $500 million of the Company's common stock. As of September 28, 2024, approximately $275.9 million of the Company's common stock has been repurchased under the share repurchase authorization, leaving approximately $224.1 million available for repurchase. During the three months ended September 28, 2024, the Company repurchased 0.4 million shares of the Company's common stock for $50.0 million, at an average cost of $140.26 per share. During the six months ended September 28, 2024, the Company repurchased 0.7 million shares of the Company's common stock for $91.0 million, at an average cost of $126.78 per share.

16. Segment Information

We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 

The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and HPMS.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.
15




ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read along with the unaudited consolidated condensed financial statements and notes thereto included in Item 1 of this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the fiscal year ended March 30, 2024, contained in our fiscal year 2024 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on May 24, 2024.  We maintain a website at investor.cirrus.com, which makes available free of charge our most recent annual report and all other filings we have made with the Commission. 

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q including Management’s Discussion and Analysis of Financial Condition and Results of Operations and certain information incorporated herein by reference contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act").  These forward-looking statements are based on expectations, estimates, forecasts and projections and the beliefs and assumptions of our management as of the filing of this Form 10-Q.  In some cases, forward-looking statements are identified by words such as “expect,” “anticipate,” “target,” “project,” “believe,” “goals,” “estimates,” “intend,” and variations of these types of words and similar expressions which are intended to identify these forward-looking statements.  In addition, any statements that refer to our plans, expectations, strategies or other characterizations of future events or circumstances are forward-looking statements.  Readers are cautioned that these forward-looking statements are predictions and are subject to risks, uncertainties and assumptions that are difficult to predict.  Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements and readers should not place undue reliance on such statements.  We undertake no obligation, and expressly disclaim any duty, to revise or update publicly any forward-looking statement for any reason.

For additional information regarding known material factors that could cause our actual results to differ from our projected results, please see “Item 1A - Risk Factors” in our 2024 Annual Report on Form 10-K filed with the Commission on May 24, 2024, and in "Part II, Item 1A - Risk Factors” within this Quarterly Report on Form 10-Q.  Readers should carefully review these risk factors, as well as those identified in other documents filed by us with the Commission. 

Overview

Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) is a leader in low-power, high-precision mixed-signal processing solutions that create innovative user experiences for the world’s top mobile and consumer applications.

The Company remains committed to our three-pronged strategy for growing our business: first, maintaining our leadership position in smartphone audio; second, increasing HPMS content in smartphones; and third, leveraging our strength in audio and HPMS to expand into additional applications and markets with new and existing components. During the second quarter of fiscal year 2025, we continued to execute on these strategic initiatives. Our next-generation custom boosted amplifier and our first 22-nanometer smart codec started shipping in recently launched smartphones. We also passed key milestones related to our laptop business as we secured our first high-volume mainstream design win with our latest PC codec and began shipping our first power product specifically designed for laptops in multiple tier-one customers’ devices; one of these new devices includes eight Cirrus Logic components. While we are in the early stages of revenue contribution from our recently introduced laptop components, we are pleased with our progress to date.

Critical Accounting Policies and Estimates

Our discussion and analysis of the Company’s financial condition and results of operations are based upon the unaudited consolidated condensed financial statements included in this report, which have been prepared in accordance with U.S. GAAP.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts.  We evaluate the estimates on an ongoing basis.  We base these estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions and conditions. 

16


There have been no significant changes during the three and six months ended September 28, 2024, to the information provided under the headings “Critical Accounting Estimates” and "Summary of Significant Accounting Policies" included in our fiscal year 2024 Annual Report on Form 10-K for the fiscal year ended March 30, 2024.

Recently Issued Accounting Pronouncements

For a discussion of recently issued accounting pronouncements, refer to Note 2 of the Notes to the Consolidated Condensed Financial Statements.

Results of Operations 

Our fiscal year is the 52- or 53-week period ending on the last Saturday in March. Fiscal year 2025 is a 52-week fiscal year. Fiscal year 2024 was a 53-week fiscal year, including a 14-week fiscal third quarter.

The following table summarizes the results of our operations for the three and six months of fiscal years 2025 and 2024, respectively, as a percentage of net sales.  All percentage amounts were calculated using the underlying data in thousands, unaudited:

Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Net sales100 %100 %100 %100 %
Gross margin52 %51 %52 %51 %
Research and development21 %22 %24 %26 %
Selling, general and administrative%%%%
Restructuring costs— %— %— %— %
Income from operations24 %22 %20 %15 %
Interest income%%%%
Interest expense— %— %— %— %
Other income (expense)— %— %— %— %
Income before income taxes26 %23 %22 %16 %
Provision for income taxes%%%%
Net income19 %16 %16 %11 %

Net Sales 

Net sales for the second quarter of fiscal year 2025 increased $60.8 million, or 13 percent, to $541.9 million from $481.1 million in the second quarter of fiscal year 2024.  Net sales from our audio products increased $33.7 million, primarily driven by higher smartphone unit volumes and increased revenue associated with next-generation products. Net sales from HPMS products increased $27.1 million for the quarter versus the second quarter of fiscal year 2024, primarily due to higher smartphone unit volumes and, to a lesser extent, revenue associated with next-generation products. Additionally, the second quarter of fiscal 2025 began and ended one week later than the comparable quarter in the prior year. Thus, it encompassed one week more of the higher-volume production associated with typical seasonal product ramps.

Net sales for the first six months of fiscal year 2025 increased $117.8 million, or 15 percent, to $915.9 million from $798.1 million for the first six months of fiscal year 2024. Net sales from our audio products increased $56.9 million, primarily driven by higher smartphone unit volumes and sales associated with next-generation products, partially offset by lower general market sales. Net sales from HPMS products increased $60.9 million for the year versus the first six months of fiscal year 2024, primarily due to higher smartphone unit volumes and sales associated with next-generation products, partially offset by lower general market sales.

International sales, including sales to U.S.-based end customers that manufacture products through contract manufacturers or plants located overseas, were approximately 100 percent and 99 percent of net sales for the second quarters of fiscal years 2025 and 2024, respectively, and 99 percent for each of the first six month periods of fiscal years 2025 and 2024. Our sales are denominated primarily in U.S. dollars. 
17



Since the components we produce are largely proprietary, we consider our end customer to be the entity specifying the use of our component in their design. These end customers may purchase our products directly from us, through distributors, or third-party manufacturers contracted to produce their designs.  For the second quarter of fiscal years 2025 and 2024, our ten largest end customers represented approximately 97 percent and 95 percent, respectively, of our net sales, and 96 percent and 94 percent of our net sales for the first six months of fiscal years 2025 and 2024, respectively.

We had one end customer, Apple Inc., that purchased through multiple contract manufacturers and represented approximately 90 percent and 88 percent of the Company’s total net sales for the second quarter of fiscal years 2025 and 2024, respectively, and 89 percent and 86 percent for the first six months of fiscal years 2025 and 2024, respectively.
 
No other end customer or distributor represented more than 10 percent of net sales for the three and six months ended September 28, 2024 or September 23, 2023.

For more information, please see "Part II, Item 1A - Risk Factors" “We depend on a limited number of customers and distributors for a substantial portion of our sales, and the loss of, or a significant reduction in orders from, or pricing on products sold to, any key customer or distributor could significantly reduce our sales and our profitability.”

Gross Margin

Gross margin was 52.2 percent in the second quarter of fiscal year 2025, up from 51.3 percent in the second quarter of fiscal year 2024, largely due to a favorable product mix, offset in part by higher supply chain costs versus the prior period.

Gross margin was 51.5 percent for the first six months of fiscal year 2025, up from 50.9 percent for the first six months of fiscal year 2024 due to a more favorable product mix, and, to a lesser extent, reduced freight costs, partially offset by higher inventory reserves, as well as costs associated with new product ramps.

Research and Development Expense

Research and development expense for the second quarter of fiscal year 2025 was $112.9 million, an increase of $8.7 million, from $104.2 million in the second quarter of fiscal year 2024. Significant drivers of the increase included increased variable compensation, employee-related, facilities-related and product development costs, offset by reduced acquisition-related expenses in the current quarter.

Research and development expense for the first six months of fiscal year 2025 was $218.3 million, an increase of $7.9 million, from $210.4 million for the first six months of fiscal year 2024 primarily due to increased variable compensation, facilities-related and employee-related costs, partially offset by reduced acquisition-related costs and an investment write-off that occurred in the first quarter of fiscal year 2024.

Selling, General and Administrative Expense

Selling, general and administrative expense for the second quarter of fiscal year 2025 was $37.8 million, an increase of $3.5 million, from $34.3 million in the second quarter of fiscal year 2024, due to increased employee-related and variable compensation expenses.

Selling, general and administrative expense for the first six months of fiscal year 2025 was $74.6 million, an increase of $4.9 million, from $69.7 million for the first six months of fiscal year 2024, primarily due to increased variable compensation costs, employee-related expenses, and lease impairment costs for the period.

Restructuring

In fiscal year 2024, the Company recorded costs related to a workforce reduction action taken in the second quarter of fiscal year 2024. Restructuring costs for the second quarter and first six months of fiscal year 2024 were $2.3 million. See Note 10 - Restructuring Costs for additional information.

Interest Income

The Company reported interest income of $8.4 million and $16.8 million for the three and six months ended September 28, 2024, respectively, and $4.0 million and $8.8 million for the three and six months ended September 23, 2023,
18


respectively. Interest income increased in the current period due to higher yields on higher combined average cash, cash equivalents and marketable securities balances, compared to the prior period.

Interest Expense
The Company reported interest expense of $0.2 million and $0.5 million for the three and six months ended September 28, 2024, respectively, and $0.2 million and $0.5 million for the three and six months ended September 23, 2023, respectively.  Interest expense consists primarily of commitment fees associated with the Company's Revolving Credit Facility (see Note 8 - Revolving Credit Facility of the Notes to the Consolidated Condensed Financial Statements).

Other Income (Expense)

For the three and six months ended September 28, 2024, the Company reported other income of an immaterial amount and $1.6 million, respectively, and $0.1 million of other expense and $0.3 million of other income for the three and six months ended September 23, 2023, respectively. This activity primarily related to non-investment related income and remeasurement on foreign currency denominated monetary assets and liabilities.   

Income Taxes

Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items and any applicable credits. 

The following table presents the provision for income taxes (in thousands) and the effective tax rates:

Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Income before income taxes$140,005 $109,408 $196,608 $132,178 
Provision for income taxes$37,865 $34,001 $52,373 $41,171 
Effective tax rate27.0 %31.1 %26.6 %31.1 %

Our income tax expense for the second quarter of fiscal year 2025 was $37.9 million compared to $34.0 million for the second quarter of fiscal year 2024, resulting in effective tax rates of 27.0 percent and 31.1 percent, respectively. Our income tax expense was $52.4 million and $41.2 million for the first six months of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 26.6 percent and 31.1 percent, respectively. Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires R&D expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, resulting in higher GILTI, which is treated as a period cost. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI. Our effective tax rates for the periods presented were higher than the federal statutory rate primarily due to these two items, partially offset by the effect of income earned in certain foreign jurisdictions that is taxed below the federal statutory rate.

Liquidity and Capital Resources 

We require cash to fund our operating expenses and working capital requirements, including outlays for inventory, capital expenditures, share repurchases, and strategic acquisitions.  Our principal sources of liquidity are cash on hand, cash generated from operations, cash generated from the sale and maturity of marketable securities, and available borrowings under our $300 million Revolving Credit Facility. 

Cash used in or generated from our operating activities is net income adjusted for certain non-cash items and changes in working capital.  Cash generated from operations was $95.4 million for the first six months of fiscal year 2025 versus $62.5 million used during the corresponding period of fiscal year 2024.  The cash flow from operations during the first six months of fiscal year 2025 was related to the cash components of our net income and a $117.9 million unfavorable change in working capital, primarily as a result of increases in accounts receivables and inventory, partially offset by increases in accounts payable and other accrued liabilities, prepaid wafer usage (related to the Capacity Reservation Agreement), and income taxes payable.  The cash flow used in operations during the corresponding period of fiscal year 2024 was related to the cash components of our
19


net income and a $216.5 million unfavorable change in working capital, primarily as a result of an increase in accounts receivables and inventory and a decrease in acquisition-related liabilities, partially offset by prepaid wafer usage (related to the Capacity Reservation Agreement) beginning in the second quarter of fiscal year 2024.       

Net cash used in investing activities was $72.0 million during the first six months of fiscal year 2025 versus $23.8 million during the first six months of fiscal year 2024.  The cash used in investing activities in the first six months of fiscal year 2025 was related to capital expenditures of $12.9 million and net purchases of marketable securities of $59.2 million.  The cash used in investing activities in the corresponding period in fiscal year 2024 was related to capital expenditures and technology investments of $20.8 million and net purchases of marketable securities of $2.9 million.

Net cash used in financing activities was $80.4 million during the first six months of fiscal year 2025 and was primarily associated with stock repurchases for the period of $91.0 million, partially offset by $10.6 million in net proceeds from the issuance of common stock, primarily related to stock option exercises. The cash used in financing activities during the first six months of fiscal year 2024 of $81.6 million was primarily associated with stock repurchases during the period of $79.1 million.

Our future capital requirements will depend on many factors, including the rate of sales growth, market acceptance of our products, the timing and extent of research and development projects, potential future acquisitions of companies or technologies, inventory build, and commitments under the Capacity Reservation Agreement with GlobalFoundries (discussed further in Note 13 - Commitments and Contingencies of the Notes to the Consolidated Condensed Financial Statements). We believe our expected future cash earnings, existing cash, cash equivalents, investment balances, and available borrowings under our Revolving Credit Facility will be sufficient to meet our capital requirements both domestically and internationally, in the short-term (i.e. the next 12 months) and in the long-term, although we could be required, or could elect, to seek additional funding prior to that time.
Revolving Credit Facility

On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries ("Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent. The Amendment updates the benchmark interest rate provisions to replace LIBOR with Term SOFR, for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.

As of September 28, 2024, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.  

See Note 8 — Revolving Credit Facility for additional information including material terms and related covenants.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risks associated with interest rates on our debt securities, currency movements on non-functional currency assets and liabilities, and the effect of market factors on the value of our marketable securities.  We assess these risks on a regular basis and have established policies that are designed to protect against the adverse effects of these and other potential exposures. We use forward contracts to manage exposure to foreign currency exchange risk attributable to certain non-U.S. dollar balance sheet exposures. Gains and losses from these foreign currency forward contracts are recognized currently in earnings along with the gains and losses resulting from remeasuring the underlying exposures.  Information about our market risks as of September 28, 2024, does not materially differ from the description of our market risks included in "Part II – Item 7A – Quantitative and Qualitative Disclosures about Market Risk” within our fiscal year 2024 Annual Report on Form 10-K filed with the Commission on May 24, 2024. For related financial statement impact see Note 5 - Derivative Financial Instruments.

20



ITEM 4.  CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

As required by Rule 13a-15(b) of the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our chief executive officer (CEO) and interim chief financial officer (CFO), the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.  Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Commission rules and forms and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. 
Based upon the evaluation, our management, including our CEO and CFO, has concluded that our disclosure controls and procedures were effective as of September 28, 2024.
Changes in control over financial reporting

There has been no change in the Company’s internal control over financial reporting during the quarter ended September 28, 2024, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 


PART II. OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

Information regarding legal proceedings to which the Company is a party is set forth in Note 14 – Legal Matters to our unaudited consolidated condensed financial statements and is incorporated herein by reference. 

ITEM 1A. RISK FACTORS

In evaluating all forward-looking statements, you should specifically consider risk factors that may cause actual results to vary from those contained in the forward-looking statements.  Various risk factors associated with our business are included in our Annual Report on Form 10-K for the year ended March 30, 2024, as filed with the Commission on May 24, 2024, and available at www.sec.gov.  Other than as set forth below, there have been no material changes to those risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended March 30, 2024.

We depend on a limited number of customers and distributors for a substantial portion of our sales, and the loss of, or a significant reduction in orders from, or pricing on products sold to, any key customer or distributor could significantly reduce our sales and our profitability.

While we generate sales from a broad base of customers worldwide, the loss of any of our key customers, or a significant reduction in sales or selling prices to any key customer, or reductions in selling prices made to retain key customer relationships, would significantly reduce our revenue, margins and earnings and adversely affect our business.  For the second quarter of fiscal years 2025 and 2024, our ten largest end customers represented approximately 97 percent and 95 percent of our net sales, respectively. For the first six months of fiscal years of 2025 and 2024, our ten largest end customers represented approximately 96 percent and 94 percent of our net sales, respectively. We had one end customer, Apple Inc., that purchased through multiple contract manufacturers and represented approximately 90 percent and 88 percent of the Company’s total net sales for the second quarter of fiscal years 2025 and 2024, respectively, and 89 percent and 86 percent for the first six months of fiscal years of 2025 and 2024, respectively.  No other end customer or distributor represented more than 10 percent of net sales for the three and six months ended September 28, 2024, or September 23, 2023.

We may not be able to maintain or increase sales to certain of our key customers for a variety of reasons, including:

- most of our customers can stop incorporating our products into their own products with limited notice to us and suffer little or no penalty;
21



- our agreements with our customers typically do not require them to purchase a minimum quantity of our products;

- many of our customers have pre-existing or concurrent relationships with our current or potential competitors that may affect the customers’ decisions to purchase our products;

- many of our customers have sufficient resources to internally develop technology solutions and semiconductor components that could replace the products that we currently supply in our customers’ end products;

- our customers face intense competition from other manufacturers that do not use our products;

- our customers may be subject to investigations and litigation that could result in injunctive or other relief that negatively impacts sales of their products, which in turn would result in a decrease in demand for our products;

- our customers regularly evaluate alternative sources of supply in order to diversify their supplier base, which increases their negotiating leverage with us and their ability to either obtain or dual-source components from other suppliers; and

- our current customers may be hesitant in some cases to award new business to us based on their desire to manage their supply chain risks around any potential over-dependence on a supplier or supply chain.

In addition, our dependence on a limited number of key customers may make it easier for them to demand favorable commercial terms or to pressure us on price reductions or to not accept price increases resulting from unexpected or additional cost increases or fees associated with our suppliers. We have experienced pricing pressure from certain key customers, and we expect that the average selling prices ("ASPs") for certain of our products will decline from time to time, potentially reducing our revenue, margins, and earnings.

Our key customer relationships often require us to develop new products that may involve significant technological challenges. Our customers frequently place considerable pressure on us to meet tight development schedules. In addition, we have entered, and may again enter in the future, into customer agreements providing for exclusivity periods during which we may only sell specified products or technology to a specific customer. Even without exclusivity periods, the products that we develop are often specific to our customer's system architecture and frequently cannot be sold to other customers. Accordingly, we have in the past and may in the future devote a substantial amount of resources to strategic relationships, which could detract from or delay our completion of other important development projects or the development of next-generation products and technologies. Notwithstanding our efforts, our customers are not always obligated to purchase new products that we develop for them, and their failure to do so could have a material effect on our operating results, financial condition, and cash flows. For example, in April 2023, we were informed that a new product that we had developed for a key customer for introduction in the fall of calendar 2023 was no longer expected to come to market as planned.

Our reliance on certain customers may continue to increase, which could heighten the risks associated with having key customers, including making us more vulnerable to significant reductions in revenue, margins, and earnings; pricing pressure; and other adverse effects on our business.

We depend on the use of information technology systems; disruptions to these systems could impact our ability to perform necessary business operations and have an adverse impact on our financial condition.

Our business relies on the security and availability of our information technology systems and solutions, such as hardware, software, cloud services, and networks. This includes, among other things, human capital solutions, financial solutions, customer relationship management solutions, design and software development solutions and tools, and data center processing. While we own and manage some of these information technology systems directly, we also rely on third-party information technology systems in the operation of our business. Our operations could be harmed and our costs could increase if any of these systems are disrupted for any reason, including information technology system failures or cyber-attacks; natural disasters; power or water shortages; political, social or economic instability including military, terrorist, or other catastrophic events; labor disruptions; insolvency of third-parties on which we rely; or other operational issues or system failures. We have experienced outages in the past and could be subjected to periods in which our systems and solutions or the third-party systems on which we rely are negatively impacted, degraded or unavailable, potentially for extended periods of time. If this were to occur, we could be subject to data loss or corruption, inability to accurately process or record transactions, reputational harm, litigation, indemnity obligations and other liabilities, and our business, revenues, profitability and financial condition could be negatively impacted.

22



ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information about purchases of equity securities that are registered by us pursuant to Section 12 of the Exchange Act during the three months ended September 28, 2024 (in thousands, except per share amounts):

Monthly PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsApproximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
June 30, 2024 - July 27, 2024— $— — $274,141 
July 28, 2024 - August 24, 2024258 $139.41 258 $238,152 
August 25, 2024 - September 28, 202498 $142.48 98 $224,147 
Total356 $140.26 356 $224,147 

(1) The Company currently has one active share repurchase authorization, the $500 million in share repurchases authorized by the Board of Directors in July 2022. Share repurchases are to be funded from existing cash and intended to be effected from time to time in accordance with applicable securities laws through the open market, including pursuant to a Rule 10b5-1 trading plan, or in privately negotiated transactions. The timing of repurchases and the actual amount purchased depend on a variety of factors including general market and economic conditions and other corporate considerations. The authorization does not have an expiration date, does not obligate the Company to repurchase any particular amount of common stock, and may be modified or suspended at any time at the Company's discretion. The Company repurchased 0.4 million shares of its common stock for an aggregate of $50.0 million during the second quarter of fiscal year 2025 under the 2022 share repurchase authorization. These shares were repurchased in the open market and were funded from existing cash. All shares of our common stock that were repurchased were retired as of September 28, 2024.

The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

23



ITEM 5.  OTHER INFORMATION

Trading Arrangements

The following table details contracts, instructions and written plans for the purchase or sale of securities, which were entered into during the second quarter of fiscal year 2025. None of our directors or Section 16 officers entered into or terminated a non-Rule 10b5-1 trading arrangement during the second quarter of fiscal year 2025.

Name and TitleAction
Trading Arrangement (1)
Date of AdoptionExpiration Date
Aggregate Number of Securities to be Purchased or Sold Pursuant to the Trading Arrangement (2)
Scott Thomas - Senior VP, General Counsel
AdoptionRule 10b5-1(c)August 9, 2024November 4, 2025
up to 14,823 to be sold
Jeff Baumgartner - VP, R&D
AdoptionRule 10b5-1(c)August 20, 2024December 31, 2025
up to 37,205 to be sold
(1) Except as indicated by footnote, each trading arrangement marked as "Rule 10b5-1(c)" is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended.
(2) Includes shares to be acquired upon the exercise of employee stock options.


ITEM 6.  EXHIBITS

The following exhibits are filed as part of or incorporated by reference into this Report:

NumberDescription
3.1
3.2
31.1
31.2
32.1*
32.2*
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
1.Incorporated by reference to Exhibit 2 to the Registrant’s Definitive Proxy Statement filed with the Commission on June 3, 2024 (Registration No. 000-17795).
2.Incorporated by reference from Registrant’s Report on Form 8-K filed with the Commission on March 8, 2023 (Registration No. 000-17795).

*    The certifications attached as Exhibits 32.1 and 32.2 accompanying this Quarterly Report on Form 10-Q are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
24





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CIRRUS LOGIC, INC.
Date:November 4, 2024/s/ Ulf Habermann
Ulf Habermann
Interim Chief Financial Officer
25

CERTIFICATION
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, John M. Forsyth, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Cirrus Logic, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date:November 4, 2024/s/ John M. Forsyth
John M. Forsyth
President and Chief Executive Officer



CERTIFICATION
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Ulf Habermann, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Cirrus Logic, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date:November 4, 2024/s/ Ulf Habermann
Ulf Habermann
Interim Chief Financial Officer



Certification Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Cirrus Logic, Inc. (the “Company”) on Form 10-Q for the period ended September 28, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John M. Forsyth, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to my knowledge:
1.The Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
Date:November 4, 2024/s/ John M. Forsyth
John M. Forsyth
President and Chief Executive Officer



Certification Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Cirrus Logic, Inc. (the “Company”) on Form 10-Q for the period ended September 28, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ulf Habermann, Interim Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to my knowledge:
1.The Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
Date:November 4, 2024/s/ Ulf Habermann
Ulf Habermann
Interim Chief Financial Officer


v3.24.3
Cover - shares
6 Months Ended
Sep. 28, 2024
Oct. 31, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 28, 2024  
Document Transition Report false  
Entity File Number 0-17795  
Entity Registrant Name CIRRUS LOGIC, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0024818  
Entity Address, Address Line One 800 W. 6th Street  
Entity Address, City or Town Austin,  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78701  
City Area Code (512)  
Local Phone Number 851-4000  
Title of 12(b) Security Common stock, $0.001 par value  
Trading Symbol CRUS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   53,139,913
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Current Fiscal Year End Date --03-29  
Entity Central Index Key 0000772406  
v3.24.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Current assets:    
Cash and cash equivalents $ 445,759 $ 502,764
Marketable securities 32,499 23,778
Accounts receivable, net 324,098 162,478
Inventories 271,765 227,248
Prepaid assets 49,594 48,047
Prepaid wafers 71,740 86,679
Other current assets 29,450 55,198
Total current assets 1,224,905 1,106,192
Long-term marketable securities 228,302 173,374
Right-of-use lease assets 133,316 138,288
Property and equipment, net 168,265 170,175
Intangibles, net 25,700 29,578
Goodwill 435,936 435,936
Deferred tax assets 48,619 48,649
Long-term prepaid wafers 37,804 60,750
Other assets 53,292 68,634
Total assets 2,356,139 2,231,576
Current liabilities:    
Accounts payable 91,899 55,545
Accrued salaries and benefits 51,861 47,612
Software license agreements 26,643 31,866
Current lease liabilities 22,800 20,640
Other accrued liabilities 36,073 30,730
Total current liabilities 229,276 186,393
Long-term liabilities:    
Non-current lease liabilities 129,806 134,576
Non-current income taxes 42,683 52,013
Software license agreements 26,223 41,073
Other long-term liabilities 24 507
Total long-term liabilities 198,736 228,169
Stockholders' equity:    
Capital stock 1,819,589 1,760,701
Accumulated earnings 107,233 58,916
Accumulated other comprehensive income (loss) 1,305 (2,603)
Total stockholders' equity 1,928,127 1,817,014
Total liabilities and stockholders' equity $ 2,356,139 $ 2,231,576
v3.24.3
Consolidated Condensed Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Income Statement [Abstract]        
Net sales $ 541,857 $ 481,063 $ 915,883 $ 798,079
Cost of sales 259,267 234,467 444,368 392,096
Gross profit 282,590 246,596 471,515 405,983
Operating expenses        
Research and development 112,925 104,205 218,288 210,420
Selling, general and administrative 37,813 34,323 74,583 69,702
Restructuring costs 0 2,319 0 2,319
Total operating expenses 150,738 140,847 292,871 282,441
Income from operations 131,852 105,749 178,644 123,542
Interest income 8,378 3,972 16,798 8,791
Interest expense (244) (243) (462) (462)
Other income (expense) 19 (70) 1,628 307
Income before income taxes 140,005 109,408 196,608 132,178
Provision for income taxes 37,865 34,001 52,373 41,171
Net income $ 102,140 $ 75,407 $ 144,235 $ 91,007
Basic earnings per share (in dollars per share) $ 1.92 $ 1.38 $ 2.70 $ 1.66
Diluted earnings per share (in dollars per share) $ 1.83 $ 1.34 $ 2.59 $ 1.61
Basic weighted average common shares outstanding (in shares) 53,275 54,503 53,354 54,683
Diluted weighted average common shares outstanding (in shares) 55,800 56,278 55,753 56,453
v3.24.3
Consolidated Condensed Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Statement of Comprehensive Income [Abstract]        
Net income $ 102,140 $ 75,407 $ 144,235 $ 91,007
Other comprehensive loss, before tax        
Foreign currency translation gain (loss) 717 (342) 359 (792)
Unrealized gain on marketable securities 4,851 259 4,493 239
Provision for income taxes (1,019) (54) (944) (50)
Comprehensive income $ 106,689 $ 75,270 $ 148,143 $ 90,404
v3.24.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Cash flows from operating activities:    
Net income $ 144,235 $ 91,007
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 24,977 23,551
Stock-based compensation expense 43,832 44,046
Deferred income taxes (913) (8,601)
Loss on retirement or write-off of long-lived assets 12 64
Other non-cash adjustments 1,191 1,608
Restructuring costs 0 2,319
Net change in operating assets and liabilities:    
Accounts receivable (161,620) (121,606)
Inventories (44,517) (95,480)
Prepaid wafers 37,885 21,058
Other assets (5,800) (6,291)
Accounts payable and other accrued liabilities 39,305 (78)
Income taxes payable 16,805 7,220
Acquisition-related liabilities 0 (21,361)
Net cash provided by (used in) operating activities 95,392 (62,544)
Cash flows from investing activities:    
Maturities and sales of available-for-sale marketable securities 13,481 18,242
Purchases of available-for-sale marketable securities (72,637) (21,191)
Purchases of property, equipment and software (12,660) (20,780)
Investments in technology (225) (57)
Net cash used in investing activities (72,041) (23,786)
Cash flows from financing activities:    
Net proceeds from the issuance of common stock 15,055 560
Repurchase of stock to satisfy employee tax withholding obligations (4,426) (3,129)
Repurchase and retirement of common stock (90,985) (79,080)
Net cash used in financing activities (80,356) (81,649)
Net decrease in cash and cash equivalents (57,005) (167,979)
Cash and cash equivalents at beginning of period 502,764 445,784
Cash and cash equivalents at end of period $ 445,759 $ 277,805
v3.24.3
Consolidated Condensed Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 25, 2023   55,098      
Beginning balance at Mar. 25, 2023 $ 1,658,282 $ 55 $ 1,670,086 $ (9,320) $ (2,539)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 91,007     91,007  
Change in unrealized gain (loss) on marketable securities, net of tax 189       189
Change in foreign currency translation adjustments (792)       (792)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   116      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (2,562)   564 (3,126)  
Repurchase and retirement of common stock (in shares)   (977)      
Repurchase and retirement of common stock (79,775) $ (1)   (79,774)  
Stock-based compensation 42,006   42,006    
Ending balance (in shares) at Sep. 23, 2023   54,237      
Ending balance at Sep. 23, 2023 1,708,355 $ 54 1,712,656 (1,213) (3,142)
Beginning balance (in shares) at Jun. 24, 2023   54,670      
Beginning balance at Jun. 24, 2023 1,656,794 $ 55 1,693,365 (33,621) (3,005)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 75,407     75,407  
Change in unrealized gain (loss) on marketable securities, net of tax 205       205
Change in foreign currency translation adjustments (342)       (342)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   78      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (2,080)     (2,080)  
Repurchase and retirement of common stock (in shares)   (511)      
Repurchase and retirement of common stock (40,920) $ (1)   (40,919)  
Stock-based compensation 19,291   19,291    
Ending balance (in shares) at Sep. 23, 2023   54,237      
Ending balance at Sep. 23, 2023 1,708,355 $ 54 1,712,656 (1,213) (3,142)
Beginning balance (in shares) at Mar. 30, 2024   53,491      
Beginning balance at Mar. 30, 2024 1,817,014 $ 53 1,760,648 58,916 (2,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 144,235     144,235  
Change in unrealized gain (loss) on marketable securities, net of tax 3,549       3,549
Change in foreign currency translation adjustments 359       359
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   359      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes 10,630   15,056 (4,426)  
Repurchase and retirement of common stock (in shares)   (718)      
Repurchase and retirement of common stock (91,492)     (91,492)  
Stock-based compensation 43,832   43,832    
Ending balance (in shares) at Sep. 28, 2024   53,132      
Ending balance at Sep. 28, 2024 1,928,127 $ 53 1,819,536 107,233 1,305
Beginning balance (in shares) at Jun. 29, 2024   53,335      
Beginning balance at Jun. 29, 2024 1,847,630 $ 53 1,792,230 58,591 (3,244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 102,140     102,140  
Change in unrealized gain (loss) on marketable securities, net of tax 3,832       3,832
Change in foreign currency translation adjustments 717       717
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   154      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes 1,652   4,859 (3,207)  
Repurchase and retirement of common stock (in shares)   (357)      
Repurchase and retirement of common stock (50,291)     (50,291)  
Stock-based compensation 22,447   22,447    
Ending balance (in shares) at Sep. 28, 2024   53,132      
Ending balance at Sep. 28, 2024 $ 1,928,127 $ 53 $ 1,819,536 $ 107,233 $ 1,305
v3.24.3
Basis of Presentation
6 Months Ended
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of PresentationThe unaudited consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”).  The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations.  As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 30, 2024, included in our Annual Report on Form 10-K filed with the Commission on May 24, 2024.  In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented.  The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses.  Actual results could differ from those estimates and assumptions.  Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.
v3.24.3
Recently Issued Accounting Pronouncements
6 Months Ended
Sep. 28, 2024
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements Recently Issued Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU requires (1) interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of a segment’s profit or loss, (2) interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, and (3) disclosure of the position and title of the CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. In the event the CODM uses more than one measure of a segment's profit or loss in assessing performance and allocation of resources, clarification of disclosure requirements is provided. Additionally, a company with a single reportable segment is required to provide all the disclosures prescribed under this ASU. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, to be applied retrospectively to all periods presented, with early adoption permitted. The Company is currently evaluating the impact of this new guidance on the financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted. The Company is currently evaluating the impact of this guidance on the financial statements and related disclosures.
v3.24.3
Marketable Securities
6 Months Ended
Sep. 28, 2024
Marketable Securities [Abstract]  
Marketable Securities Marketable Securities
The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the Consolidated Condensed Balance Sheet as "Marketable securities", within the short-term or long-term classification, as appropriate, based on the original maturity.

The following table is a summary of available-for-sale securities at September 28, 2024 (in thousands):
As of September 28, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$245,715 $3,513 $(40)$249,188 
U.S. Treasury securities10,212 135 (6)10,341 
Agency discount notes385 — (2)383 
Commercial paper889 — — 889 
Total securities$257,201 $3,648 $(48)$260,801 

The Company typically invests in highly-rated securities with original maturities generally ranging from one to three years. The Company's specifically identified gross unrealized losses, relating to securities with total amortized costs of approximately $10.8 million at September 28, 2024, were immaterial. Securities in a continuous unrealized loss position for
more than 12 months as of September 28, 2024 had an aggregate amortized cost of $8.7 million and an immaterial amount of aggregate unrealized loss. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of September 28, 2024, the Company does not consider any of its investments to be impaired.

The following table is a summary of available-for-sale securities at March 30, 2024 (in thousands):
As of March 30, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$186,194 $115 $(916)$185,393 
U.S. Treasury securities9,850 — (81)9,769 
Agency discount notes1,135 — (11)1,124 
Commercial paper866 — — 866 
Total securities$198,045 $115 $(1,008)$197,152 

The Company's specifically identified gross unrealized losses of $1.0 million related to securities with total amortized costs of approximately $172.1 million at March 30, 2024. Securities in a continuous unrealized loss position for more than 12 months as of March 30, 2024 had an aggregate amortized cost of $25.0 million and an aggregate unrealized loss of $0.3 million. As of March 30, 2024, the Company did not consider any of its investments to be impaired.

The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):
September 28, 2024March 30, 2024
AmortizedEstimatedAmortizedEstimated
CostFair ValueCostFair Value
Within 1 year$32,450 $32,499 $24,071 $23,778 
After 1 year224,751 228,302 173,974 173,374 
Total$257,201 $260,801 $198,045 $197,152 
v3.24.3
Fair Value of Financial Instruments
6 Months Ended
Sep. 28, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, U.S Treasury securities, securities of U.S. government-sponsored enterprises, and commercial paper and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term
marketable securities.  The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.

The Company's long-term revolving credit facility, described in Note 8 - Revolving Credit Facility, bears interest at a base rate plus applicable margin or forward-looking secured overnight financing rate ("Term SOFR") plus 10 basis points plus applicable margin. As of September 28, 2024, there are no amounts drawn under the facility and the fair value is zero.

As of September 28, 2024 and March 30, 2024, the Company has no Level 3 assets or liabilities.  There were no transfers between Level 1, Level 2, or Level 3 measurements for the three months ended September 28, 2024. 

The following summarizes the fair value of our financial instruments at September 28, 2024 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:    
Cash equivalents    
Money market funds$383,276 $— $— $383,276 
Available-for-sale securities    
Corporate debt securities$— $249,188 $— $249,188 
U.S. Treasury securities10,341 — — 10,341 
Agency discount notes— 383 — 383 
Commercial paper— 889 — 889 
$10,341 $250,460 $— $260,801 

The following summarizes the fair value of our financial instruments at March 30, 2024 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:
Cash equivalents    
Money market funds$439,065 $— $— $439,065 
Certificates of deposit— 400 — 400 
$439,065 $400 $— $439,465 
Available-for-sale securities    
Corporate debt securities$— $185,393 $— $185,393 
U.S. Treasury securities9,769 — — 9,769 
Agency discount notes— 1,124 — 1,124 
Commercial paper— 866 — 866 
$9,769 $187,383 $— $197,152 
v3.24.3
Derivative Financial Instruments
6 Months Ended
Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within "Other income (expense)" in the Consolidated Condensed Statements of Income. The Company does not apply hedge accounting to these foreign currency derivative instruments.

As of September 28, 2024, the Company held one foreign currency forward contract denominated in British Pound Sterling with a notional value of $17.4 million. The fair value of this contract was not material as of September 28, 2024.

The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023Location
Gain (loss) recognized in income:
Foreign currency forward contracts$684 $(195)$652 $(473)Other income (expense)
v3.24.3
Accounts Receivable, net
6 Months Ended
Sep. 28, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]  
Accounts Receivable, net Accounts Receivable, net
The following are the components of accounts receivable, net (in thousands):
September 28,March 30,
20242024
Gross accounts receivable$324,098 $162,478 
Allowance for doubtful accounts— — 
Accounts receivable, net$324,098 $162,478 
v3.24.3
Inventories
6 Months Ended
Sep. 28, 2024
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories are comprised of the following (in thousands):
September 28,March 30,
20242024
Work in process$183,001 $130,842 
Finished goods88,764 96,406 
$271,765 $227,248 
v3.24.3
Revolving Credit Facility
6 Months Ended
Sep. 28, 2024
Debt Disclosure [Abstract]  
Revolving Credit Facility Revolving Credit Facility
On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the "Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative
agent. The Amendment updates the benchmark interest rate provisions to replace the London interbank offered rate ("LIBOR") with the forward-looking overnight financing rate ("Term SOFR"), for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.

Borrowings under the Revolving Credit Facility may, at Cirrus Logic’s election, bear interest at either (a) a base rate plus the applicable margin ("Base Rate Loans") or (b) a Term SOFR rate plus a 10 basis point credit spread adjustment plus the applicable margin. The applicable margin ranges from 0% to 0.75% per annum for Base Rate Loans and 1.00% to 1.75% per annum for SOFR Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of four consecutive fiscal quarters (the “Consolidated Leverage Ratio”). A Commitment Fee accrues at a rate per annum ranging from 0.175% to 0.275% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders.

The Revolving Credit Facility contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $200 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 3.00 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 3.00 to 1.00 (the “Consolidated Interest Coverage Ratio”). The Second Amended Credit Agreement also contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. Further, the Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations.
As of September 28, 2024, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.
v3.24.3
Revenues
6 Months Ended
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal ("HPMS").

Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Audio Products$316,588 $282,855 $535,558 $478,661 
HPMS Products225,269 198,208 380,325 319,418 
$541,857 $481,063 $915,883 $798,079 

The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
China$325,742 $279,066 $531,450 $469,928 
United States2,471 4,883 7,687 7,042 
Rest of World213,644 197,114 376,746 321,109 
$541,857 $481,063 $915,883 $798,079 
v3.24.3
Restructuring Costs
6 Months Ended
Sep. 28, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Costs Restructuring CostsIn fiscal year 2023, the Company decided to abandon or sublease office space at various properties worldwide to align our real property lease arrangements with our anticipated operating needs. In addition, in fiscal year 2024, the Company announced a workforce reduction of approximately 5% of its global employees. The Company incurred associated severance and other related charges of $2.3 million in the second quarter of fiscal year 2024. As of September 28, 2024, remaining restructuring-related liabilities were immaterial and are expected to be substantially paid out in cash during fiscal year 2025.
v3.24.3
Income Taxes
6 Months Ended
Sep. 28, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, and any applicable income tax credits.

The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Income before income taxes$140,005 $109,408 $196,608 $132,178 
Provision for income taxes$37,865 $34,001 $52,373 $41,171 
Effective tax rate27.0 %31.1 %26.6 %31.1 %

Our income tax expense was $37.9 million and $34.0 million for the second quarters of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 27.0 percent and 31.1 percent, respectively. Our income tax expense was $52.4 million and $41.2 million for the first six months of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 26.6 percent and 31.1 percent, respectively. 

Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires research and development ("R&D") expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, resulting in higher global intangible low-taxed income ("GILTI"), which is treated as a period cost. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI. Our effective tax rates for the periods presented were higher than the federal statutory rate primarily due to these two items, partially offset by the effect of income earned in certain foreign jurisdictions that is taxed below the federal statutory rate.

The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns.  At September 28, 2024, the Company had unrecognized tax benefits of $32.1 million, all of which would impact the effective tax rate if recognized.  The Company’s total unrecognized tax benefits are classified as “Non-current income taxes" in the Consolidated Condensed Balance Sheets. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes.  As of September 28, 2024, the balance of accrued interest and penalties, net of tax, was $10.6 million. 

On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved in the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits. The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2017 through 2019 and 2021 through 2024 remain open to examination by the major taxing jurisdictions in which the Company operates.  
The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service ("IRS").  The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies. The final Revenue Agent’s Report asserted additional tax of approximately $168.3 million, excluding interest, and imposed penalties of approximately $63.7 million. The Company does not agree with the IRS's positions and has not accrued an additional liability. In July 2024, the Company entered the administrative dispute process with the IRS Independent Office of Appeals ("IRS Appeals"). We intend to vigorously dispute the proposed adjustments and pursue judicial remedies if an acceptable outcome cannot be reached with IRS Appeals. The Company expects it could take a number of years to reach resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes adequate amounts have been reserved in accordance with ASC 740 for any adjustments to the provision for income taxes that may ultimately result. However, if the IRS prevails in these matters, the ultimate amount of assessed tax, interest, and penalties, if any, could be material and may have an adverse impact on our financial position, results of operations, and cash flows in future periods. The Company is not under an income tax audit in any other major taxing jurisdiction.
v3.24.3
Net Income Per Share
6 Months Ended
Sep. 28, 2024
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  These potentially dilutive items consist primarily of outstanding stock options and restricted stock grants.

The following table details the calculation of basic and diluted earnings per share for the three and six months ended September 28, 2024 and September 23, 2023 (in thousands, except per share amounts):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Numerator:    
Net income$102,140 $75,407 $144,235 $91,007 
Denominator:    
Weighted average shares outstanding53,275 54,503 53,354 54,683 
Effect of dilutive securities2,525 1,775 2,399 1,770 
Weighted average diluted shares55,800 56,278 55,753 56,453 
Basic earnings per share$1.92 $1.38 $2.70 $1.66 
Diluted earnings per share$1.83 $1.34 $2.59 $1.61 
The weighted outstanding shares excluded from our diluted calculation for the three and six months ended September 28, 2024 were 8 thousand and 229 thousand, respectively, as the shares were anti-dilutive. The weighted outstanding shares excluded from our diluted calculation for the three and six months ended September 23, 2023 were 393 thousand and 364 thousand, respectively, as the shares were anti-dilutive.
v3.24.3
Commitment and Contingencies
6 Months Ended
Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Capacity Reservation Agreement

On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GlobalFoundries to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”).

The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments. In exchange for GlobalFoundries’ capacity commitment, the Company paid a $60 million non-refundable capacity reservation fee, which is amortized over the Commitment Period. The balance of this reservation fee is $24 million as of September 28, 2024, and is
recorded in "Other current assets" and "Other assets" on the Consolidated Condensed Balance Sheets within the short-term or long-term classification, as appropriate. In addition, the Company pre-paid GlobalFoundries $195 million for future wafer purchases, which are credited back to the Company as a portion of the price of wafers purchased, which began in the Company's second fiscal quarter of 2024. The balance of the prepayment is $110 million at September 28, 2024, and is currently recorded in "Long-term prepaid wafers" and "Prepaid wafers" on the Consolidated Condensed Balance Sheets.
v3.24.3
Legal Matters
6 Months Ended
Sep. 28, 2024
Loss Contingency, Information about Litigation Matters [Abstract]  
Legal Matters Legal Matters
From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities.  We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate.  We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.    

Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows.  However, we are engaged in various legal actions in the normal course of business.  There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.
v3.24.3
Stockholders' Equity
6 Months Ended
Sep. 28, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders' Equity
Common Stock 

The Company issued a net 0.2 million and 0.4 million of shares of common stock during each of the three and six months ended September 28, 2024, and issued a net 0.1 million of shares of common stock for both the three and six months ended September 23, 2023 pursuant to the Company's equity incentive plans.

Share Repurchase Program 

The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity. As of September 28, 2024, the Company has accrued approximately $1.8 million related to this excise tax. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.
In July 2022, the Board of Directors authorized the repurchase of up to $500 million of the Company's common stock. As of September 28, 2024, approximately $275.9 million of the Company's common stock has been repurchased under the share repurchase authorization, leaving approximately $224.1 million available for repurchase. During the three months ended September 28, 2024, the Company repurchased 0.4 million shares of the Company's common stock for $50.0 million, at an average cost of $140.26 per share. During the six months ended September 28, 2024, the Company repurchased 0.7 million shares of the Company's common stock for $91.0 million, at an average cost of $126.78 per share.
v3.24.3
Segment Information
6 Months Ended
Sep. 28, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 

The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and HPMS.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.
v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Pay vs Performance Disclosure        
Net income $ 102,140 $ 75,407 $ 144,235 $ 91,007
v3.24.3
Insider Trading Arrangements
3 Months Ended 6 Months Ended
Sep. 28, 2024
shares
Sep. 28, 2024
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
The following table details contracts, instructions and written plans for the purchase or sale of securities, which were entered into during the second quarter of fiscal year 2025. None of our directors or Section 16 officers entered into or terminated a non-Rule 10b5-1 trading arrangement during the second quarter of fiscal year 2025.

Name and TitleAction
Trading Arrangement (1)
Date of AdoptionExpiration Date
Aggregate Number of Securities to be Purchased or Sold Pursuant to the Trading Arrangement (2)
Scott Thomas - Senior VP, General Counsel
AdoptionRule 10b5-1(c)August 9, 2024November 4, 2025
up to 14,823 to be sold
Jeff Baumgartner - VP, R&D
AdoptionRule 10b5-1(c)August 20, 2024December 31, 2025
up to 37,205 to be sold
(1) Except as indicated by footnote, each trading arrangement marked as "Rule 10b5-1(c)" is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended.
(2) Includes shares to be acquired upon the exercise of employee stock options.
Non-Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Terminated false  
Scott Thomas [Member]    
Trading Arrangements, by Individual    
Name Scott Thomas  
Title Senior VP, General Counsel  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 9, 2024  
Rule 10b5-1 Arrangement Terminated false  
Expiration Date November 4, 2025  
Arrangement Duration 452 days  
Aggregate Available 14,823 14,823
Jeff Baumgartner [Member]    
Trading Arrangements, by Individual    
Name Jeff Baumgartner  
Title VP, R&D  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 20, 2024  
Rule 10b5-1 Arrangement Terminated false  
Expiration Date December 31, 2025  
Arrangement Duration 498 days  
Aggregate Available 37,205 37,205
v3.24.3
Recently Issued Accounting Pronouncements (Policies)
6 Months Ended
Sep. 28, 2024
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU requires (1) interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of a segment’s profit or loss, (2) interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, and (3) disclosure of the position and title of the CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. In the event the CODM uses more than one measure of a segment's profit or loss in assessing performance and allocation of resources, clarification of disclosure requirements is provided. Additionally, a company with a single reportable segment is required to provide all the disclosures prescribed under this ASU. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, to be applied retrospectively to all periods presented, with early adoption permitted. The Company is currently evaluating the impact of this new guidance on the financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted. The Company is currently evaluating the impact of this guidance on the financial statements and related disclosures.
Marketable Securities The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the Consolidated Condensed Balance Sheet as "Marketable securities", within the short-term or long-term classification, as appropriate, based on the original maturity.
Fair Value of Financial Instruments
The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, U.S Treasury securities, securities of U.S. government-sponsored enterprises, and commercial paper and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term
marketable securities.  The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.
Revenues
Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal ("HPMS").
Segment Information
We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 

The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and HPMS.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.
v3.24.3
Marketable Securities (Tables)
6 Months Ended
Sep. 28, 2024
Marketable Securities [Abstract]  
Schedule of Available-for-sale Securities
The following table is a summary of available-for-sale securities at September 28, 2024 (in thousands):
As of September 28, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$245,715 $3,513 $(40)$249,188 
U.S. Treasury securities10,212 135 (6)10,341 
Agency discount notes385 — (2)383 
Commercial paper889 — — 889 
Total securities$257,201 $3,648 $(48)$260,801 
The following table is a summary of available-for-sale securities at March 30, 2024 (in thousands):
As of March 30, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$186,194 $115 $(916)$185,393 
U.S. Treasury securities9,850 — (81)9,769 
Agency discount notes1,135 — (11)1,124 
Commercial paper866 — — 866 
Total securities$198,045 $115 $(1,008)$197,152 
Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity
The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):
September 28, 2024March 30, 2024
AmortizedEstimatedAmortizedEstimated
CostFair ValueCostFair Value
Within 1 year$32,450 $32,499 $24,071 $23,778 
After 1 year224,751 228,302 173,974 173,374 
Total$257,201 $260,801 $198,045 $197,152 
v3.24.3
Fair Value of Financial Instruments (Tables)
6 Months Ended
Sep. 28, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets and Liabilities
The following summarizes the fair value of our financial instruments at September 28, 2024 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:    
Cash equivalents    
Money market funds$383,276 $— $— $383,276 
Available-for-sale securities    
Corporate debt securities$— $249,188 $— $249,188 
U.S. Treasury securities10,341 — — 10,341 
Agency discount notes— 383 — 383 
Commercial paper— 889 — 889 
$10,341 $250,460 $— $260,801 

The following summarizes the fair value of our financial instruments at March 30, 2024 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:
Cash equivalents    
Money market funds$439,065 $— $— $439,065 
Certificates of deposit— 400 — 400 
$439,065 $400 $— $439,465 
Available-for-sale securities    
Corporate debt securities$— $185,393 $— $185,393 
U.S. Treasury securities9,769 — — 9,769 
Agency discount notes— 1,124 — 1,124 
Commercial paper— 866 — 866 
$9,769 $187,383 $— $197,152 
v3.24.3
Derivative Financial Instruments (Tables)
6 Months Ended
Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Before-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments
The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023Location
Gain (loss) recognized in income:
Foreign currency forward contracts$684 $(195)$652 $(473)Other income (expense)
v3.24.3
Accounts Receivable, net (Tables)
6 Months Ended
Sep. 28, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]  
Components of Accounts Receivable, net
The following are the components of accounts receivable, net (in thousands):
September 28,March 30,
20242024
Gross accounts receivable$324,098 $162,478 
Allowance for doubtful accounts— — 
Accounts receivable, net$324,098 $162,478 
v3.24.3
Inventories (Tables)
6 Months Ended
Sep. 28, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories are comprised of the following (in thousands):
September 28,March 30,
20242024
Work in process$183,001 $130,842 
Finished goods88,764 96,406 
$271,765 $227,248 
v3.24.3
Revenues (Tables)
6 Months Ended
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Audio Products$316,588 $282,855 $535,558 $478,661 
HPMS Products225,269 198,208 380,325 319,418 
$541,857 $481,063 $915,883 $798,079 

The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
China$325,742 $279,066 $531,450 $469,928 
United States2,471 4,883 7,687 7,042 
Rest of World213,644 197,114 376,746 321,109 
$541,857 $481,063 $915,883 $798,079 
v3.24.3
Income Taxes (Tables)
6 Months Ended
Sep. 28, 2024
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Taxes and Effective Tax Rates
The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Income before income taxes$140,005 $109,408 $196,608 $132,178 
Provision for income taxes$37,865 $34,001 $52,373 $41,171 
Effective tax rate27.0 %31.1 %26.6 %31.1 %
v3.24.3
Net Income Per Share (Tables)
6 Months Ended
Sep. 28, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table details the calculation of basic and diluted earnings per share for the three and six months ended September 28, 2024 and September 23, 2023 (in thousands, except per share amounts):
Three Months EndedSix Months Ended
September 28,September 23,September 28,September 23,
2024202320242023
Numerator:    
Net income$102,140 $75,407 $144,235 $91,007 
Denominator:    
Weighted average shares outstanding53,275 54,503 53,354 54,683 
Effect of dilutive securities2,525 1,775 2,399 1,770 
Weighted average diluted shares55,800 56,278 55,753 56,453 
Basic earnings per share$1.92 $1.38 $2.70 $1.66 
Diluted earnings per share$1.83 $1.34 $2.59 $1.61 
v3.24.3
Marketable Securities (Schedule of Available-for-sale Securities) (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 257,201 $ 198,045
Gross Unrealized Gains 3,648 115
Gross Unrealized Losses (48) (1,008)
Estimated Fair Value (Net Carrying Amount) 260,801 197,152
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 245,715 186,194
Gross Unrealized Gains 3,513 115
Gross Unrealized Losses (40) (916)
Estimated Fair Value (Net Carrying Amount) 249,188 185,393
U.S. Treasury securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 10,212 9,850
Gross Unrealized Gains 135 0
Gross Unrealized Losses (6) (81)
Estimated Fair Value (Net Carrying Amount) 10,341 9,769
Agency discount notes    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 385 1,135
Gross Unrealized Gains 0 0
Gross Unrealized Losses (2) (11)
Estimated Fair Value (Net Carrying Amount) 383 1,124
Commercial paper    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 889 866
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Estimated Fair Value (Net Carrying Amount) $ 889 $ 866
v3.24.3
Marketable Securities (Narrative) (Details) - USD ($)
$ in Thousands
6 Months Ended
Sep. 28, 2024
Mar. 30, 2024
Debt Securities, Available-for-sale [Line Items]    
Amortized cost on available for sale securities held at gross unrealized loss $ 10,800 $ 172,100
Securities in a continuous unrealized loss position for more than 12 months, amortized cost 8,700 25,000
Gross unrealized loss $ (48) (1,008)
Securities in a continuous unrealized loss position for more than 12 months, aggregate unrealized loss   $ 300
Minimum    
Debt Securities, Available-for-sale [Line Items]    
Maturity period for highly-rated securities 1 year  
Maximum    
Debt Securities, Available-for-sale [Line Items]    
Maturity period for highly-rated securities 3 years  
v3.24.3
Marketable Securities (Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity) (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Amortized Cost    
Within 1 year $ 32,450 $ 24,071
After 1 year 224,751 173,974
Amortized Cost 257,201 198,045
Estimated Fair Value    
Within 1 year 32,499 23,778
After 1 year 228,302 173,374
Estimated Fair Value (Net Carrying Amount) $ 260,801 $ 197,152
v3.24.3
Fair Value of Financial Instruments (Narrative) (Details) - USD ($)
Mar. 20, 2023
Sep. 28, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amounts drawn under the credit facility   $ 0
Credit facility, fair value   $ 0
Second Amended Credit Agreement Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | Line of Credit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Basis spread on variable rate 0.10%  
v3.24.3
Fair Value of Financial Instruments (Schedule of Fair Value of Financial Assets and Liabilities) (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   $ 439,465
Available-for-sale securities $ 260,801 197,152
Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   439,065
Available-for-sale securities 10,341 9,769
Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   400
Available-for-sale securities 250,460 187,383
Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   0
Available-for-sale securities 0 0
Corporate debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 249,188 185,393
Corporate debt securities | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Corporate debt securities | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 249,188 185,393
Corporate debt securities | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
U.S. Treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 10,341 9,769
U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 10,341 9,769
U.S. Treasury securities | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
U.S. Treasury securities | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Agency discount notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 383 1,124
Agency discount notes | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Agency discount notes | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 383 1,124
Agency discount notes | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 889 866
Commercial paper | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Commercial paper | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 889 866
Commercial paper | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 383,276 439,065
Money market funds | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 383,276 439,065
Money market funds | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 0 0
Money market funds | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 0 0
Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   400
Certificates of deposit | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   0
Certificates of deposit | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   400
Certificates of deposit | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   $ 0
v3.24.3
Derivative Financial Instruments (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
USD ($)
derivativeContract
Sep. 23, 2023
USD ($)
Sep. 28, 2024
USD ($)
derivativeContract
Sep. 23, 2023
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]        
Number of foreign currency derivatives held | derivativeContract 1   1  
Notional value of foreign currency forward contract $ 17,400   $ 17,400  
Foreign currency forward contracts | Not Designated as Hedging Instrument        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain (loss) recognized in income $ 684 $ (195) $ 652 $ (473)
v3.24.3
Accounts Receivable, net (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]    
Gross accounts receivable $ 324,098 $ 162,478
Allowance for doubtful accounts 0 0
Accounts receivable, net $ 324,098 $ 162,478
v3.24.3
Inventories (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Inventory Disclosure [Abstract]    
Work in process $ 183,001 $ 130,842
Finished goods 88,764 96,406
Total inventories $ 271,765 $ 227,248
v3.24.3
Revolving Credit Facility (Details) - Second Amended Credit Agreement Revolving Credit Facility - USD ($)
Mar. 20, 2023
Jul. 08, 2021
Sep. 28, 2024
Line of Credit Facility [Line Items]      
Line of credit facility maximum borrowing capacity   $ 300,000,000  
Debt covenant, exclusion of unrestricted cash and cash equivalents for ratio of consolidated funded indebtedness   $ 200,000,000  
Debt covenant, maximum consolidated net leverage ratio   3.00  
Debt covenant, minimum consolidated interest coverage ratio   3.00  
Amount outstanding     $ 0
Minimum      
Line of Credit Facility [Line Items]      
Line of credit facility, unused capacity, commitment fee percentage   0.175%  
Maximum      
Line of Credit Facility [Line Items]      
Line of credit facility, unused capacity, commitment fee percentage   0.275%  
Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | Line of Credit      
Line of Credit Facility [Line Items]      
Basis spread on variable rate 0.10%    
Secured Overnight Financing Rate (SOFR) | Minimum | Revolving Credit Facility | Line of Credit      
Line of Credit Facility [Line Items]      
Basis spread on variable rate 1.00%    
Secured Overnight Financing Rate (SOFR) | Maximum | Revolving Credit Facility | Line of Credit      
Line of Credit Facility [Line Items]      
Basis spread on variable rate 1.75%    
Variable Rate Component Two | Minimum | Revolving Credit Facility | Line of Credit      
Line of Credit Facility [Line Items]      
Basis spread on variable rate   0.00%  
Variable Rate Component Two | Maximum | Revolving Credit Facility | Line of Credit      
Line of Credit Facility [Line Items]      
Basis spread on variable rate   0.75%  
v3.24.3
Revenues (Summary of Product Lines) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Disaggregation of Revenue [Line Items]        
Net sales $ 541,857 $ 481,063 $ 915,883 $ 798,079
Audio Products        
Disaggregation of Revenue [Line Items]        
Net sales 316,588 282,855 535,558 478,661
HPMS Products        
Disaggregation of Revenue [Line Items]        
Net sales $ 225,269 $ 198,208 $ 380,325 $ 319,418
v3.24.3
Revenues (Summary of Geographic Disaggregation) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Disaggregation of Revenue [Line Items]        
Net sales $ 541,857 $ 481,063 $ 915,883 $ 798,079
China        
Disaggregation of Revenue [Line Items]        
Net sales 325,742 279,066 531,450 469,928
United States        
Disaggregation of Revenue [Line Items]        
Net sales 2,471 4,883 7,687 7,042
Rest of World        
Disaggregation of Revenue [Line Items]        
Net sales $ 213,644 $ 197,114 $ 376,746 $ 321,109
v3.24.3
Restructuring Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Mar. 30, 2024
Restructuring Cost and Reserve [Line Items]          
Restructuring costs $ 0 $ 2,319 $ 0 $ 2,319  
Employee Severance          
Restructuring Cost and Reserve [Line Items]          
Percentage of reduction in workforce         5.00%
v3.24.3
Income Taxes (Provision for Income Taxes) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Income Tax Disclosure [Abstract]        
Income before income taxes $ 140,005 $ 109,408 $ 196,608 $ 132,178
Provision for income taxes $ 37,865 $ 34,001 $ 52,373 $ 41,171
Effective tax rate 27.00% 31.10% 26.60% 31.10%
v3.24.3
Income Taxes (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Income Tax Disclosure [Abstract]        
Income tax expense $ 37,865 $ 34,001 $ 52,373 $ 41,171
Effective tax rate 27.00% 31.10% 26.60% 31.10%
Gross unrecognized tax benefits $ 32,100   $ 32,100  
Penalties and interest accrued $ 10,600   10,600  
Estimate of possible loss     168,300  
Estimate of possible loss, penalties expense     $ 63,700  
v3.24.3
Net Income Per Share (Calculation of Basic and Diluted Earnings Per Share) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Numerator:        
Net income $ 102,140 $ 75,407 $ 144,235 $ 91,007
Denominator:        
Weighted average shares outstanding (in shares) 53,275 54,503 53,354 54,683
Effect of dilutive securities (in shares) 2,525 1,775 2,399 1,770
Weighted average diluted shares (in shares) 55,800 56,278 55,753 56,453
Basic earnings per share (in dollars per share) $ 1.92 $ 1.38 $ 2.70 $ 1.66
Diluted earnings per share (in dollars per share) $ 1.83 $ 1.34 $ 2.59 $ 1.61
v3.24.3
Net Income Per Share (Narrative) (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Earnings Per Share [Abstract]        
Weighted average shares outstanding excluded from diluted calculation (in shares) 8 393 229 364
v3.24.3
Commitment and Contingencies (Details) - USD ($)
$ in Millions
Jul. 28, 2021
Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]    
Payments for capacity reservation fee $ 60  
Capacity reservation fee remaining   $ 24
Prepaid wafers $ 195  
Prepaid wafers balance   $ 110
v3.24.3
Stockholders' Equity (Common Stock) (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Stockholders' Equity Note [Abstract]        
Common stock issued as part of stock incentive plan (in shares) 0.2 0.1 0.4 0.1
v3.24.3
Stockholders' Equity (Share Repurchase Program) (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
3 Months Ended 6 Months Ended 26 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Jul. 31, 2022
Equity, Class of Treasury Stock [Line Items]            
Accrued excise tax $ 1,800   $ 1,800   $ 1,800  
Common stock repurchased 50,291 $ 40,920 91,492 $ 79,775    
July 2022 Repurchase Program            
Equity, Class of Treasury Stock [Line Items]            
Common stock approved under the share repurchase program           $ 500,000
Common stock repurchased 50,000   91,000   275,900  
Common stock available for repurchase $ 224,100   $ 224,100   $ 224,100  
Common stock repurchased (in shares) 0.4   0.7      
Average cost per share repurchased (in dollars per share) $ 140.26   $ 126.78      
v3.24.3
Segment Information (Details)
6 Months Ended
Sep. 28, 2024
product_line
segment
Segment Reporting [Abstract]  
Number of reportable segments | segment 1
Number of product lines | product_line 2

Cirrus Logic (NASDAQ:CRUS)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Cirrus Logic Charts.
Cirrus Logic (NASDAQ:CRUS)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Cirrus Logic Charts.